Fig. 5From: The prevalence, risk factors, and prognostic value of venous thromboembolism in ovarian cancer patients receiving chemotherapy: a systematic review and meta-analysisSensitivity analyses for prevalence of venous thromboembolism (VTE) in ovarian cancer patients receiving chemotherapyBack to article page